Tiemann Investment Advisors, LLC Eli Lilly & CO Transaction History

Tiemann Investment Advisors, LLC

$230 Million
Q3 2024

A detailed history of Tiemann Investment Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tiemann Investment Advisors, LLC holds 1,867 shares of LLY stock, worth $1.4 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

1,867

Previous 1,980 5.71%

Holding current value

$1.4 Million

Previous $1.79 Million 7.7%

% of portfolio

0.72%

Previous 0.8%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $87,251 - $108,482	-113 Reduced 5.71%	1,867 $1.65 Million
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $19,571 - $24,544	-27 Reduced 1.35%	1,980 $1.79 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $14,805 - $19,807	25 Added 1.26%	2,007 $1.56 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $9,978 - $11,763	-19 Reduced 0.95%	1,982 $1.16 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $434 - $599	-1 Reduced 0.05%	2,001 $1.07 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $3,507 - $4,689	10 Added 0.5%	2,002 $938,000
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $26,403 - $31,009	85 Added 4.46%	1,992 $684,000
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $40,193 - $46,833	125 Added 7.01%	1,907 $697,000
Q3 2022 Nov 15, 2022	SELL	$296.48 - $337.87 $13,341 - $15,204	-45 Reduced 2.46%	1,782 $576,000
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $22,855 - $26,836	82 Added 4.7%	1,827 $592,000
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $8,214 - $10,208	35 Added 2.05%	1,745 $500,000
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $11,242 - $13,952	-50 Reduced 2.84%	1,710 $472,000
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $11,080 - $13,635	-50 Reduced 2.76%	1,760 $407,000
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $1,805 - $2,335	-10 Reduced 0.55%	1,810 $415,000
Q1 2021 May 12, 2021	BUY	$164.32 - $212.72 $192,254 - $248,882	1,170 Added 180.0%	1,820 $340,000
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $205,892 - $266,538	-1,253 Reduced 65.84%	650 $215,000
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $3,655 - $4,228	-25 Reduced 1.3%	1,903 $282,000
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $44,882 - $54,015	329 Added 20.58%	1,928 $317,000
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $29,403 - $36,418	-275 Reduced 14.67%	1,599 $210,000
Q3 2019 Nov 15, 2019	SELL	$106.79 - $116.16 $29,367 - $31,944	-275 Reduced 12.8%	1,874 $210,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $184,513 - $230,609	2,149 New	2,149 $231,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiemann Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiemann Investment Advisors, LLC with notifications on news.

Account

Tiemann Investment Advisors, LLC Eli Lilly & CO Transaction History